144 related articles for article (PubMed ID: 8821514)
1. [Bioequivalence of nifedipine sustained-release formulations in comparison to standard preparations in solid state].
Herrmann R
Arzneimittelforschung; 1996 Jan; 46(1):28-34. PubMed ID: 8821514
[TBL] [Abstract][Full Text] [Related]
2. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
[TBL] [Abstract][Full Text] [Related]
3. [The bioequivalence of two nifedipine sustained-release formulations after single administration in steady state].
Meyer FP; Banditt P
Arzneimittelforschung; 1993 Jun; 43(6):646-50. PubMed ID: 8352817
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence and relative bioavailability of a new diltiazem sustained release formulation.
Scheiwe MW; Lankhaar G; Kleinbloesem CH
Arzneimittelforschung; 1996 Oct; 46(10):960-3. PubMed ID: 8931888
[TBL] [Abstract][Full Text] [Related]
5. [Bioavailability of two verapamil formulations following repeated administration in steady-state conditions. An open, two-period, crossover study].
Heintz B; Müller A; Lenhard G; Schütz M; Hutt HJ
Arzneimittelforschung; 1996 Nov; 46(11):1060-3. PubMed ID: 9065315
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
[TBL] [Abstract][Full Text] [Related]
7. Human bioequivalence study of a new nifedipine containing retard filmtablet after single and repeated administration.
Klebovich I; Drabant S; Horvai G; Nemes KB; Grézal G; Horváth V; Hrabéczy-Páll A; Kocsi E; Cseh A; Balogh J; Farsang C
Arzneimittelforschung; 1997 May; 47(5):598-603. PubMed ID: 9205772
[TBL] [Abstract][Full Text] [Related]
8. Determination of nifedipine in human plasma and its use in bioequivalence study.
Guo Y; Dai J; Qian G; Guo N; Ma Z; Guo X
Int J Pharm; 2007 Aug; 341(1-2):91-6. PubMed ID: 17507190
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic interactions of nifedipine and quinidine.
Hippius M; Henschel L; Sigusch H; Tepper J; Brendel E; Hoffmann A
Pharmazie; 1995 Sep; 50(9):613-6. PubMed ID: 7480098
[TBL] [Abstract][Full Text] [Related]
10. Aiming for steady 24-hour plasma concentrations: a comparison of two calcium antagonist and beta-blocker combinations.
Eriksson M; Nyberg G; Lidman K; Olofsson B; Bergstrand R
Blood Press Suppl; 1993; 1():16-21. PubMed ID: 7909705
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and bioavailability of three different galenic nifedipine preparations.
Pabst G; Lutz D; Molz KH; Dahmen W; Jaeger H
Arzneimittelforschung; 1986 Feb; 36(2):256-60. PubMed ID: 3964332
[TBL] [Abstract][Full Text] [Related]
12. Relative bioavailability and bioequivalence study of theophylline sustained release formulations.
Vergin H; Mahr G; Winterhalter B; Wigand R
Arzneimittelforschung; 2003; 53(9):635-9. PubMed ID: 14558437
[TBL] [Abstract][Full Text] [Related]
13. Food interaction pharmacokinetic study of cordaflex 20 mg retard filmtablet in healthy volunteers.
Balogh Nemes K; Horváth V; Grézal G; Horvai G; Hrabéczy-Páll A; Kocsi E; Drabant S; Csörgö M; Renczes G; Klebovich I
Int J Clin Pharmacol Ther; 1998 May; 36(5):263-9. PubMed ID: 9629990
[TBL] [Abstract][Full Text] [Related]
14. [Comparative human pharmacokinetic studies of 20 mg nifedipine-containing Cordaflex and Adalat film coated retared tablets].
Klebovich I; Horvai G; Grézal G; Baloghné NK; Horváth V; Kocsi E; Balogh J; Cseh A; Farsang C
Acta Pharm Hung; 1996 Jan; 66(1):29-39. PubMed ID: 8714363
[TBL] [Abstract][Full Text] [Related]
15. [Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].
Lutz D; Pabst G; Dahmen W; Molz KH; Jaeger H
Arzneimittelforschung; 1985; 35(12):1840-2. PubMed ID: 4096741
[TBL] [Abstract][Full Text] [Related]
16. The relative bioavailability of two marketed controlled release diltiazem dosage forms at steady state in healthy volunteers.
Lippert CL; Arumugham T; Bhargava VO; Eller M; Weir SJ
Biopharm Drug Dispos; 1996 Jan; 17(1):43-53. PubMed ID: 8991490
[TBL] [Abstract][Full Text] [Related]
17. The kinetics of nifedipine release from porous hydrophilic matrices and the pharmacokinetics in man.
Leucuta SE
Pharmazie; 1988 Dec; 43(12):845-8. PubMed ID: 3247376
[TBL] [Abstract][Full Text] [Related]
18. Relative bioavailability study of two nifedipine tablet formulations in healthy male volunteers.
Niopas I; Daftsios AC; Xanthakis I; Nikolaidis N
Int J Clin Pharmacol Ther; 2000 Jun; 38(6):309-14. PubMed ID: 10890580
[TBL] [Abstract][Full Text] [Related]
19. [The bioequivalence of two different batches of two nifedipine controlled-release preparations with deficient batch conformity in in vitro liberation studies].
Theiss U; Gebhardt E; Müller J
Arzneimittelforschung; 1992 May; 42(5):629-32. PubMed ID: 1530675
[TBL] [Abstract][Full Text] [Related]
20. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
